Welcome to LookChem.com Sign In|Join Free
  • or
8-hydroxy-15,16-dinor-labdan-13-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

16736-51-9

Post Buying Request

16736-51-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16736-51-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 16736-51-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,3 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16736-51:
(7*1)+(6*6)+(5*7)+(4*3)+(3*6)+(2*5)+(1*1)=119
119 % 10 = 9
So 16736-51-9 is a valid CAS Registry Number.

16736-51-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (+)-8α-hydroxy-14,15-bisnorlabdan-13-one

1.2 Other means of identification

Product number -
Other names 8-hydroxy-14,15-dinor-labdan-13-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16736-51-9 SDS

16736-51-9Relevant academic research and scientific papers

An improved synthesis of rhinocerotinoic acid

Gray, Christopher A.,Davies-Coleman, Michael T.,Rivett, Douglas E. A.

, p. 165 - 173 (2003)

The stereoselective synthesis of E-rhinocerotinoic acid has been achieved in five steps from (-)-sclareol in an overall yield of 32%. This constitutes a significant improvement on the previous synthesis of this anti-inflammatory compound.

Synthesis of a Novel Diterpenoid Rearrangement Product

Bendall, Justin G.,Cambie, Richard C.,Moratti, Stephen C.,Rutledge, Peter S.,Woodgate, Paul D.

, p. 1747 - 1756 (1995)

The two intermediates postulated in the rearrangement of the labdane diterpenoid octahydronaphthopyranone (2) into the octahydronaphthofuranone (4) have been synthesized and coupled, thereby providing support for a previously proposed rearrangement mechanism.

Degradation of the side chain of (-)-sclareol: A very short synthesis of nor-ambreinolide and ambrox

Barrero,Alvarez-Manzaneda,Chahboun,Arteaga

, p. 3631 - 3643 (2007/10/03)

The synthesis of nor-Ambreinolide (8) from (-)-sclareol (1) was carried out by treatment with KMnO4-Ac2O and further alkaline hydrolysis. 8 was directly transformed into (-)-ambrox (11) by reduction with metal borohydride in the presence of Lewis acids.

Oxidative degradation of the sclareol side chain: hemisyntheses of ambergris derivatives using in the key steps palladium complexes or ruthenium tetroxide generated in situ

Zahra, Jean-Pierre,Chauvet, Frederic,Coste-Maniere, Ivan,Martres, Paul,Perfetti, Patricia,Waegell, Bernard

, p. 1001 - 1024 (2007/10/03)

We report the hemisyntheses of various ambergris-type derivatives: ambraoxide 4, Ambrox 8, 13-methylambraoxide 13, ambraketal 14, norambraketal 15, non-norambraketal 16 and dioxepane 53.Sclareol 12 is used as starting material because it is currently available from Salvia sclarea.The key steps involve an oxidative degradation of the sclareol 12 side chain, using either palladium complexes or ruthenium tetroxide generated in situ. - Keywords: sclareol; Ambrox; ambraoxide; 13-methylambraoxide; ambraketal; norambraketal; nor-norambraketal; farnesylic aldehyde; palladium complex; ruthenium tetroxide generated in situ; oxidative degradation

INVESTIGATION OF THE PRODUCTS OF THE OZONOLYSIS OF NEOABIENOLS

Koltsa, M. N.,Mironov, G. N.,Aryku, A. N.,Vlad, P. F.

, p. 36 - 42 (2007/10/02)

The ozonolysis of a mixture of 13Z- and 13E-neoabienols (I and III) leads, depending on the conditions, either to 8α-hydroxy-14,15-bis-norlabd-11-en-13-one (IV) or to 8α-hydroxdriman-11-oic acid (VI) or to driman-8α,11-diol (VII).Compound (IV) undergoes hydrogenation smoothly with the formation of a mixture of 8α-hydroxy-14,15-bisnorlabdan-13-one (X) and "sclareol oxide" (XI).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 16736-51-9